Though more research is needed to understand who might benefit from GLP-1 agonists for addiction, early studies suggest that the approach holds promise.

Across 21 countries, proportion of 12-month person-disorders receiving effective treatment was 6.9 percent. (HealthDay News) — A small number of individuals with mental and substance use disorders ...

The vast majority of people who have a substance use disorder (SUD) never seek treatment. At most, 10% of adults with a drug or alcohol use disorder have entered any type of inpatient or outpatient ...

Glucagon-like peptide-1 receptor agonists (GLP-1RAs), originally developed for treating diabetes, work by stimulating insulin secretion and suppressing glucagon release, thereby helping regulate blood ...

During that time, drug overdose deaths decreased by 4% nationwide, marking the first time overdose deaths declined since the ...

A decision about how to spend settlement funds in Carter County, Kentucky, which was hit hard by the opioid epidemic, offers ...

After a meeting at the Mesilla Valley Public Housing Authority, Athena Huckaby saw a man across the street who had fallen out of a wheelchair yelling for help. She and a stranger got him back into his ...

The physical and mental demands of construction jobs play a huge role in why the industry has the highest rates of addiction and suicide. The Construction Working Minds Summit is striving to address ...

RFK Jr. plans to investigate SSRI and antidepressant use, particularly among children and teens, as part of the “Make America ...

Alcohol addiction has the power to destroy lives - and not just the drinker's. For while around 1 per cent of us are thought ...

President Donald Trump and HHS Secretary Robert F. Kennedy Jr. said they will be studying the "threat" to children posed by antidepressants and obesity medications.

The combination of prescribed central nervous system stimulants, such as drugs that relieve ADHD symptoms, with prescribed ...